Adjuvant chemotherapy for non-small-cell lung cancer: a fading effect?

MeSH terms

• Antineoplastic Combined Chemotherapy Protocols / adverse effects
• Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
• Biomarkers, Tumor / analysis
• Carboplatin / administration & dosage
• Carcinoma, Non-Small-Cell Lung / drug therapy*
• Carcinoma, Non-Small-Cell Lung / metabolism
• Carcinoma, Non-Small-Cell Lung / mortality
• Carcinoma, Non-Small-Cell Lung / pathology
• Chemotherapy, Adjuvant
• Disease-Free Survival
• Evidence-Based Medicine
• Humans
• Lung Neoplasms / drug therapy*
• Lung Neoplasms / metabolism
• Lung Neoplasms / mortality
• Lung Neoplasms / pathology
• Neoplasm Staging
• Paclitaxel / administration & dosage
• Patient Selection
• Risk Assessment
• Survival Analysis
• Time Factors
• Treatment Outcome